Skip to main content
ConductScienceScienceDex
zenodorestricted

MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: A clinico-laboratory assessment

<p>Introduction</p><p>This database includes the raw data linked with the paper "MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: A clinico-laboratory assessment " to be published on "Journal of Neurology Neurosurgery and Psychiatry".&nbsp;</p><p>In this paper, we reported clinical, radiological and laboratory data concerning thirty-eight individuals diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) to assess the impact of the criteria-based MOG-IgG testing in MOGAD diagnosis.&nbsp;</p><p>Methods</p><p>Thirty-eight serum samples of MOG-IgG1-positive MOGAD patients were titred on MOG-IgG LCBA and FCBA, and the presence of supporting features for MOGAD assessed. MOGAD criteria were evaluated in three testing scenarios: a) FCBA without titration; b) FCBA with titration; c) LCBA with titration.</p><p>Results (in brief)</p><p>FCBA without titration failed to reach MOGAD diagnosis in 11/38 patients (28.9%, negative results in 5, lack of supporting features in 6). Patients with unconfirmed diagnosis had optic neuritis (ON, n=8), or transverse myelitis (TM, n=3). FCBA with titration allowed MOGAD diagnosis in 4 additional patients. Correlation between LCBA and FCBA titres was moderate (Spearman's rho 0.6, p&lt;0.001).</p>

ShareScore

20/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
8
Harmonization
4
Access
8
Reuse readiness
0
Engagement
0

Topics

Dataset details

Repository
zenodo
Published
November 1, 2023
License
cc-by-4.0
DOI
10.5281/zenodo.10067021

Scored with release 0.9.0

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.